✦ LIBER ✦

Rosuvastatin may be more effective than atorvastatin in African-Americans with hypercholesterolemia

✍ Scribed by Francisco A. Fonseca; Maria Cristina O Izar; Matthew A Silva; Angeliki Karapanos; Herbert Schuster; Debbie Singh

Book ID: 119231195
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 84 KB
Volume: 10
Category: Article
ISSN: 1361-2611
DOI: 10.1016/j.ebcm.2006.04.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

OP15 Immunosuppressive co-treatment with

OP15 Immunosuppressive co-treatment with adalimumab (ADA) may be more effective than ADA monotherapy for maintaining remission in Crohn's disease (CD)

✍ C. Reenaers; E. Louis; J. Belaiche; S. Keshav; S. Travis 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 46 KB

Sa1892 Immunosuppressive Co-Treatment Wi

Sa1892 Immunosuppressive Co-Treatment With Adalimumab (ADA) May Be More Effective Than Ada Monotherapy for Maintaining Remission in Crohn's Disease (CD)

✍ Reenaers, Catherine; Louis, Edouard; Belaiche, Jacques; Keshav, Satish; Travis, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Rosuvastatin (20, 40 and 80 MG) reduces

Rosuvastatin (20, 40 and 80 MG) reduces LDL-C, raises HDL-C and achieves treatment goals more effectively than atorvastatin (20, 40 and 80 MG) in patients with heterozygous familial hypercholesterolaemia

✍ Stein, E.; Strutt, K.L.; Miller, E.; Southworth, H. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 348 KB

B cell depletion may be more effective t

B cell depletion may be more effective than switching to an alternative anti–tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti–tumor necrosis factor agents

✍ Axel Finckh; Adrian Ciurea; Laure Brulhart; Diego Kyburz; Burkhard Möller; Silvi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

## Abstract ## Objective Patients with rheumatoid arthritis (RA) in whom the response to anti–tumor necrosis factor (anti‐TNF) therapy is inadequate have several therapeutic options, such as switching to an alternative anti‐TNF agent or initiating B cell–depleting therapy with rituximab (RTX). Alt

Anastrozole is safer and may be more eff

Anastrozole is safer and may be more effective than tamoxifen in postmenopausal women with early-stage breast cancer: Abstracted from: Baum M, Buzdar A, Cuzick J, et al. The ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer. Cancer 2003;98:1802–10

✍ Hetty Carraway; Antonio C. Wolff 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 151 KB

MAGNA CARTAThe Great CharterPreamble

📂 Fiction 🌐 English ⚖ 11 KB 👁 18 views